14-DAY TAILORED PCR-GUIDED TRIPLE THERAPY VERSUS 14-DAY NON-BISMUTH CONCOMITANT QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A MULTICENTER, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL, THE HEPYSE TRIAL

Aurelien Amiot  ¹     Jeremy Hacoon  ²     Frederic Heluwaert  ³     Francois Mion  ⁴     Dominique Lamarque  ⁵     Driffa Moussata  ⁶     Jean-Charles Delchier     Etienne Audureau     Sylvie Bastuji-Garin    
¹ Henri Mondor Hospital, APHP, Creteil, France
² Henri Mondor University Hospital, Creteil, France
³ Annecy General Hospital, Annecy, France
⁴ Hospices Civils de Lyon, Lyon, France
⁵ Versailles University- Ambroise Pare, Boulogne Billancourt, France
⁶ Lyon Sud Hospital Gastroenterology GETAID Group, Pierre Bénite, France

Topic
Stomach & H. Pylori

Session
H. pylori at interfaces (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)